Shionogi Aims to Begin Global Phase 3 Trial of Covid-19 Pill Late-February
[ad_1] By Peter Landers TOKYO–Japanese drugmaker Shionogi & Co. said Monday that it plans to start a global Phase 3 trial of its Covid-19 pill as soon as late February and is in discussions with U.S. and European regulators over the trial. Shionogi said a Phase 2a trial showed that the virus was eliminated more […]
Continue Reading